Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Single Center
100%
Patient Outcomes
100%
Rheumatoid Arthritis
100%
Inception Cohort
100%
Disease Activity Score 28 (DAS28)
100%
Biological Disease-modifying Antirheumatic Drugs (bDMARDs)
57%
Remission
28%
Disease Duration
28%
Disease Activity
28%
Disease Remission
28%
Medical Files
14%
Drug Treatment
14%
Monotherapy
14%
Therapeutic Target
14%
Disease Control
14%
C-reactive Protein
14%
Clinical Variables
14%
Rheumatologists
14%
Outpatient Clinic
14%
Rheumatology
14%
Cross-sectional Observational Study
14%
Routine Clinical Practice
14%
Combined Treatment
14%
Rheumatoid Factor
14%
Treatment Variable
14%
Disease-modifying Antirheumatic Drugs (DMARDs)
14%
Tight Control
14%
Low Disease Activity
14%
Treat-to-target
14%
Consecutive Patients
14%
Anti-cyclic Citrullinated Peptide (anti-CCP)
14%
Medicine and Dentistry
Cross Sectional Study
100%
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Disease Activity
60%
Disease Modifying Antirheumatic Drug
60%
Spontaneous Remission
40%
Disease-Modifying Antirheumatic Drug
40%
Drug Therapy
20%
Monotherapy
20%
Outpatient
20%
C Reactive Protein
20%
Disease Duration
20%
Rheumatology
20%
Rheumatoid Factor
20%
Diseases
20%
Peptide
20%